TMPRSS4 correlates with colorectal cancer pathological stage and regulates cell proliferation and self-renewal ability

References

• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63:11 - 30; http://dx.doi.org/10.3322/caac.21166; PMID: 23335087
   PubMed Web of Science ®Google Scholar
• Gao P, Song YX, Wang ZN, Xu YY, Tong LL, Sun JX, Yu M, Xu HM. Is the prediction of prognosis not improved by the seventh edition of the TNM classification for colorectal cancer? Analysis of the surveilla006Ece, epidemiology, and end results (SEER) database. BMC Cancer 2013; 13:123; http://dx.doi.org/10.1186/1471-2407-13-123; PMID: 23496812
   PubMed Web of Science ®Google Scholar
• Sadahiro S, Suzuki T, Ishikawa K, Nakamura T, Tanaka Y, Masuda T, Mukoyama S, Yasuda S, Tajima T, Makuuchi H, et al. Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years. Hepatogastroenterology 2003; 50:1362 - 6; PMID: 14571738
   PubMed Web of Science ®Google Scholar
• Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119:1420 - 8; http://dx.doi.org/10.1172/JCI39104; PMID: 19487818
   PubMed Web of Science ®Google Scholar
• Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011; 147:275 - 92; http://dx.doi.org/10.1016/j.cell.2011.09.024; PMID: 22000009
   PubMed Web of Science ®Google Scholar
• Scheel C, Weinberg RA. Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin Cancer Biol 2012; 22:396 - 403; http://dx.doi.org/10.1016/j.semcancer.2012.04.001; PMID: 22554795
   PubMed Web of Science ®Google Scholar
• Netzel-Arnett S, Hooper JD, Szabo R, Madison EL, Quigley JP, Bugge TH, Antalis TM. Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer. Cancer Metastasis Rev 2003; 22:237 - 58; http://dx.doi.org/10.1023/A:1023003616848; PMID: 12784999
   PubMed Web of Science ®Google Scholar
• Szabo R, Bugge TH. Type II transmembrane serine proteases in development and disease. Int J Biochem Cell Biol 2008; 40:1297 - 316; http://dx.doi.org/10.1016/j.biocel.2007.11.013; PMID: 18191610
   PubMed Web of Science ®Google Scholar
• Yuan X, Zheng X, Lu D, Rubin DC, Pung CY, Sadler JE. Structure of murine enterokinase (enteropeptidase) and expression in small intestine during development. Am J Physiol 1998; 274:G342 - 9; PMID: 9486188
   PubMed Web of Science ®Google Scholar
• Guipponi M, Tan J, Cannon PZ, Donley L, Crewther P, Clarke M, Wu Q, Shepherd RK, Scott HS. Mice deficient for the type II transmembrane serine protease, TMPRSS1/hepsin, exhibit profound hearing loss. Am J Pathol 2007; 171:608 - 16; http://dx.doi.org/10.2353/ajpath.2007.070068; PMID: 17620368
   PubMed Web of Science ®Google Scholar
• Scott HS, Kudoh J, Wattenhofer M, Shibuya K, Berry A, Chrast R, Guipponi M, Wang J, Kawasaki K, Asakawa S, et al. Insertion of beta-satellite repeats identifies a transmembrane protease causing both congenital and childhood onset autosomal recessive deafness. Nat Genet 2001; 27:59 - 63; http://dx.doi.org/10.1038/83768; PMID: 11137999
   PubMed Web of Science ®Google Scholar
• Ohler A, Becker-Pauly C. Morpholino knockdown of the ubiquitously expressed transmembrane serine protease TMPRSS4a in zebrafish embryos exhibits severe defects in organogenesis and cell adhesion. Biol Chem 2011; 392:653 - 64; http://dx.doi.org/10.1515/bc.2011.070; PMID: 21657981
   PubMed Web of Science ®Google Scholar
• Choi SY, Bertram S, Glowacka I, Park YW, Pöhlmann S. Type II transmembrane serine proteases in cancer and viral infections. Trends Mol Med 2009; 15:303 - 12; http://dx.doi.org/10.1016/j.molmed.2009.05.003; PMID: 19581128
   PubMed Web of Science ®Google Scholar
• Kim S, Kang HY, Nam EH, Choi MS, Zhao XF, Hong CS, Lee JW, Lee JH, Park YK. TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin alpha5 and its signaling pathways. Carcinogenesis 2010; 31:597 - 606; http://dx.doi.org/10.1093/carcin/bgq024; PMID: 20118200
   PubMed Web of Science ®Google Scholar
• Kang S, Min HJ, Kang MS, Jung MG, Kim S. Discovery of novel 2-hydroxydiarylamide derivatives as TMPRSS4 inhibitors. Bioorg Med Chem Lett 2013; 23:1748 - 51; http://dx.doi.org/10.1016/j.bmcl.2013.01.055; PMID: 23414802
   PubMed Web of Science ®Google Scholar
• Liang B, Wu M, Bu Y, Zhao A, Xie F. Prognostic value of TMPRSS4 expression in patients with breast cancer. Med Oncol 2013; 30:497; http://dx.doi.org/10.1007/s12032-013-0497-8; PMID: 23420063
   PubMed Web of Science ®Google Scholar
• Cheng D, Kong H, Li Y. TMPRSS4 as a poor prognostic factor for triple-negative breast cancer. Int J Mol Sci 2013; 14:14659 - 68; http://dx.doi.org/10.3390/ijms140714659; PMID: 23857060
   PubMed Web of Science ®Google Scholar
• Jung H, Lee KP, Park SJ, Park JH, Jang YS, Choi SY, Jung JG, Jo K, Park DY, Yoon JH, et al. TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition. Oncogene 2008; 27:2635 - 47; http://dx.doi.org/10.1038/sj.onc.1210914; PMID: 17968309
   PubMed Web of Science ®Google Scholar
• Chaipan C, Kobasa D, Bertram S, Glowacka I, Steffen I, Tsegaye TS, Takeda M, Bugge TH, Kim S, Park Y, et al. Proteolytic activation of the 1918 influenza virus hemagglutinin. J Virol 2009; 83:3200 - 11; http://dx.doi.org/10.1128/JVI.02205-08; PMID: 10825129
   PubMed Web of Science ®Google Scholar
• Bahgat MM, Błazejewska P, Schughart K. Inhibition of lung serine proteases in mice: a potentially new approach to control influenza infection. Virol J 2011; 8:27; http://dx.doi.org/10.1128/JVI.02205-08; PMID: 19158246
   PubMed Web of Science ®Google Scholar
• Wallrapp C, Hähnel S, Müller-Pillasch F, Burghardt B, Iwamura T, Ruthenbürger M, Lerch MM, Adler G, Gress TM. A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer. Cancer Res 2000; 60:2602 - 6; http://dx.doi.org/10.1186/1743-422X-8-27; PMID: 21251300
   PubMed Web of Science ®Google Scholar
• Kebebew E, Peng M, Reiff E, Duh QY, Clark OH, McMillan A. ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy. Ann Surg 2005; 242:353 - 61, discussion 361-3; PMID: 16135921
   PubMed Web of Science ®Google Scholar
• Nguyen TH, Weber W, Havari E, Connors T, Bagley RG, McLaren R, Nambiar PR, Madden SL, Teicher BA, Roberts B, et al. Expression of TMPRSS4 in non-small cell lung cancer and its modulation by hypoxia. Int J Oncol 2012; 41:829 - 38; PMID: 22692880
   PubMed Web of Science ®Google Scholar
• Larzabal L, Nguewa PA, Pio R, Blanco D, Sanchez B, Rodríguez MJ, Pajares MJ, Catena R, Montuenga LM, Calvo A. Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology. Br J Cancer 2011; 105:1608 - 14; http://dx.doi.org/10.1038/bjc.2011.432; PMID: 22067904
   PubMed Web of Science ®Google Scholar
• Kebebew E, Peng M, Reiff E, McMillan A. Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms. Cancer 2006; 106:2592 - 7; http://dx.doi.org/10.1002/cncr.21922; PMID: 16688775
   PubMed Web of Science ®Google Scholar
• Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002; 298:1911 - 2; http://dx.doi.org/10.1126/science.1072682; PMID: 12471242
   PubMed Web of Science ®Google Scholar
• Bacus SS, Gudkov AV, Lowe M, Lyass L, Yung Y, Komarov AP, Keyomarsi K, Yarden Y, Seger R. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Oncogene 2001; 20:147 - 55; http://dx.doi.org/10.1038/sj.onc.1204062; PMID: 11313944
   PubMed Web of Science ®Google Scholar
• Suh Y, Yoon CH, Kim RK, Lim EJ, Oh YS, Hwang SG, An S, Yoon G, Gye MC, Yi JM, et al. Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells. Oncogene 2013; 32:4873 - 82; http://dx.doi.org/10.1038/onc.2012.505; PMID: 23160379
   PubMed Web of Science ®Google Scholar
• Yoon CH, Kim MJ, Park MJ, Park IC, Hwang SG, An S, Choi YH, Yoon G, Lee SJ. Claudin-1 acts through c-Abl-protein kinase Cdelta (PKCdelta) signaling and has a causal role in the acquisition of invasive capacity in human liver cells. J Biol Chem 2010; 285:226 - 33; http://dx.doi.org/10.1074/jbc.M109.054189; PMID: 19897486
   PubMed Web of Science ®Google Scholar
• Shiozaki A, Bai XH, Shen-Tu G, Moodley S, Takeshita H, Fung SY, Wang Y, Keshavjee S, Liu M. Claudin 1 mediates TNFα-induced gene expression and cell migration in human lung carcinoma cells. PLoS One 2012; 7:e38049; http://dx.doi.org/10.1371/journal.pone.0038049; PMID: 22675434
   PubMedGoogle Scholar
• Ikenouchi J, Matsuda M, Furuse M, Tsukita S. Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. J Cell Sci 2003; 116:1959 - 67; http://dx.doi.org/10.1242/jcs.00389; PMID: 12668723
   PubMed Web of Science ®Google Scholar
• Bezdekova M, Brychtova S, Sedlakova E, Langova K, Brychta T, Belej K. Analysis of snail-1, e-cadherin and claudin-1 expression in colorectal adenomas and carcinomas. Int J Mol Sci 2012; 13:1632 - 43; http://dx.doi.org/10.3390/ijms13021632; PMID: 22408413
   PubMed Web of Science ®Google Scholar
• Morel AP, Lièvre M, Thomas C, Hinkal G, Ansieau S, Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 2008; 3:e2888; http://dx.doi.org/10.1371/journal.pone.0002888; PMID: 18682804
   PubMed Web of Science ®Google Scholar
• Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133:704 - 15; http://dx.doi.org/10.1016/j.cell.2008.03.027; PMID: 18485877
   PubMed Web of Science ®Google Scholar
• Sanders MA, Majumdar AP. Colon cancer stem cells: implications in carcinogenesis. Front Biosci (Landmark Ed) 2011; 16:1651 - 62; http://dx.doi.org/10.2741/3811; PMID: 21196254
   PubMed Web of Science ®Google Scholar
• Mao Z, Sun J, Feng B, Ma J, Zang L, Dong F, Zhang D, Zheng M. The metastasis suppressor, N-myc downregulated gene 1 (NDRG1), is a prognostic biomarker for human colorectal cancer. PLoS One 2013; 8:e68206; http://dx.doi.org/10.1371/journal.pone.0068206; PMID: 23874544
   PubMedGoogle Scholar
• Dong TT, Zhou HM, Wang LL, Feng B, Lv B, Zheng MH. Salinomycin selectively targets ‘CD133+’ cell subpopulations and decreases malignant traits in colorectal cancer lines. Ann Surg Oncol 2011; 18:1797 - 804; http://dx.doi.org/10.1245/s10434-011-1561-2; PMID: 21267784
   PubMed Web of Science ®Google Scholar